Evogene PE Ratio 2012-2024 | EVGN

Current and historical p/e ratio for Evogene (EVGN) from 2012 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Evogene PE ratio as of October 02, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Evogene PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-10-02 2.90 0.00
2024-06-30 6.50 $-3.96 0.00
2024-03-31 7.50 $-4.60 0.00
2023-12-31 8.40 $-5.30 0.00
2023-09-30 5.87 $-4.70 0.00
2023-06-30 10.70 $-5.50 0.00
2023-03-31 6.30 $-5.90 0.00
2022-12-31 7.00 $-6.40 0.00
2022-09-30 8.30 $-7.50 0.00
2022-06-30 7.70 $-7.80 0.00
2022-03-31 13.00 $-7.20 0.00
2021-12-31 16.40 $-6.90 0.00
2021-09-30 26.40 $-7.60 0.00
2021-06-30 34.20 $-7.40 0.00
2021-03-31 50.40 $-7.50 0.00
2020-12-31 47.00 $-8.20 0.00
2020-09-30 39.60 $-8.10 0.00
2020-06-30 10.00 $-8.00 0.00
2020-03-31 11.80 $-8.00 0.00
2019-12-31 15.20 $-7.10 0.00
2019-09-30 15.80 $-7.00 0.00
2019-06-30 16.10 $-7.30 0.00
2019-03-31 18.30 $-7.60 0.00
2018-12-31 19.80 $-8.20 0.00
2018-09-30 31.10 $-8.30 0.00
2018-06-30 28.60 $-8.40 0.00
2018-03-31 31.75 $-8.30 0.00
2017-12-31 30.70 $-8.10 0.00
2017-09-30 44.40 $-8.30 0.00
2017-06-30 50.60 $-8.30 0.00
2017-03-31 53.47 $-8.30 0.00
2016-12-31 51.00 $-7.70 0.00
2016-09-30 63.80 $-7.30 0.00
2016-06-30 62.40 $-6.60 0.00
2016-03-31 65.10 $-6.80 0.00
2015-12-31 80.50 $-6.80 0.00
2015-09-30 82.50 $-6.50 0.00
2015-06-30 88.40 $-6.90 0.00
2015-03-31 88.20 $-6.20 0.00
2014-12-31 92.10 $-5.80 0.00
2014-09-30 131.60 $-5.90 0.00
2014-06-30 163.80 $-4.80 0.00
2014-03-31 190.50 $-4.00 0.00
2013-12-31 196.50 $-3.20 0.00
2013-09-30 152.00 $-1.40 0.00
2013-06-30 128.00 $-1.10 0.00
2013-03-31 101.00 $-0.90 0.00
2012-12-31 94.00 $-0.70 0.00
2012-09-30 75.00 $0.40 187.50
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.013B $0.006B
Evogene is a leading computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. Incorporating a deep understanding of biology and leveraging Big Data and Artificial Intelligence, Evogene established its unique technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. Evogene holds a number of subsidiaries utilizing the CPB platform to develop human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $172.117B 17.22
Vertex Pharmaceuticals (VRTX) United States $121.246B 0.00
Regeneron Pharmaceuticals (REGN) United States $115.406B 27.25
Bristol Myers Squibb (BMY) United States $107.249B 38.61
Gilead Sciences (GILD) United States $104.505B 17.86
CSL (CSLLY) Australia $96.396B 0.00
GSK (GSK) United Kingdom $83.523B 9.69
Alnylam Pharmaceuticals (ALNY) United States $35.441B 0.00
Argenex SE (ARGX) Netherlands $32.725B 0.00
BioNTech SE (BNTX) Germany $28.515B 0.00
Biogen (BIIB) United States $27.792B 11.73
Moderna (MRNA) United States $24.574B 0.00
BeiGene (BGNE) Cayman Islands $22.457B 0.00
Illumina (ILMN) United States $20.547B 140.20
Genmab (GMAB) Denmark $15.979B 19.96
BioMarin Pharmaceutical (BMRN) United States $13.311B 39.38
Incyte (INCY) United States $13.108B 850.75
Vaxcyte (PCVX) United States $12.895B 0.00
Exact Sciences (EXAS) United States $12.572B 0.00
Insmed (INSM) United States $12.524B 0.00
Bio-Techne Corp (TECH) United States $12.401B 48.55
Sarepta Therapeutics (SRPT) United States $11.666B 265.93
QIAGEN (QGEN) Netherlands $10.249B 21.64
Bio-Rad Laboratories (BIO.B) United States $9.106B 30.17
Legend Biotech (LEGN) United States $8.656B 0.00
Ascendis Pharma (ASND) Denmark $8.540B 0.00
Roivant Sciences (ROIV) United Kingdom $8.408B 0.00
Repligen (RGEN) United States $8.162B 124.56
Intra-Cellular Therapies (ITCI) United States $7.677B 0.00
Revolution Medicines (RVMD) United States $7.545B 0.00
Exelixis (EXEL) United States $7.502B 23.07
Halozyme Therapeutics (HALO) United States $7.175B 18.88
Viking Therapeutics (VKTX) United States $6.869B 0.00
Nuvalent (NUVL) United States $6.675B 0.00
Zealand Pharma (ZLDPF) Denmark $6.336B 0.00
Cytokinetics (CYTK) United States $6.189B 0.00
Blueprint Medicines (BPMC) United States $5.701B 0.00
Avidity Biosciences (RNA) United States $5.326B 0.00
Krystal Biotech (KRYS) United States $5.214B 348.98
Ultragenyx Pharmaceutical (RARE) United States $5.208B 0.00
Alkermes (ALKS) Ireland $4.747B 16.67
ADMA Biologics Inc (ADMA) United States $4.608B 76.04
Biohaven (BHVN) United States $4.592B 0.00
Arcellx (ACLX) United States $4.378B 0.00
Axsome Therapeutics (AXSM) United States $4.299B 0.00
Immunovant (IMVT) United States $4.164B 0.00
Denali Therapeutics (DNLI) United States $4.105B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.876B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.486B 0.00
Merus (MRUS) Netherlands $3.417B 0.00
Apellis Pharmaceuticals (APLS) United States $3.378B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.304B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.165B 0.00
Amicus Therapeutics (FOLD) United States $3.162B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.059B 0.00
Kymera Therapeutics (KYMR) United States $2.876B 0.00
Guardant Health (GH) United States $2.721B 0.00
Geron (GERN) United States $2.658B 0.00
Iovance Biotherapeutics (IOVA) United States $2.616B 0.00
Protagonist Therapeutics (PTGX) United States $2.614B 16.93
IDEAYA Biosciences (IDYA) United States $2.596B 0.00
Apogee Therapeutics (APGE) United States $2.579B 0.00
Bavarian Nordic (BVNRY) Denmark $2.568B 13.87
Edgewise Therapeutics (EWTX) United States $2.561B 0.00
Twist Bioscience (TWST) United States $2.543B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.538B 85.00
ImmunityBio (IBRX) United States $2.508B 0.00
Zai Lab (ZLAB) China $2.476B 0.00
CG Oncology (CGON) United States $2.475B 0.00
Myriad Genetics (MYGN) United States $2.455B 0.00
Structure Therapeutics (GPCR) United States $2.413B 0.00
SpringWorks Therapeutics (SWTX) United States $2.393B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $2.355B 0.00
Vera Therapeutics (VERA) United States $2.348B 0.00
Janux Therapeutics (JANX) United States $2.321B 0.00
Keros Therapeutics (KROS) United States $2.243B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.230B 20.12
Neumora Therapeutics (NMRA) United States $2.160B 0.00
Celldex Therapeutics (CLDX) United States $2.148B 0.00
Akero Therapeutics (AKRO) United States $2.002B 0.00
Novavax (NVAX) United States $1.972B 0.00
Vericel (VCEL) United States $1.964B 0.00
Intellia Therapeutics (NTLA) United States $1.950B 0.00
Beam Therapeutics (BEAM) United States $1.929B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.914B 0.00
Galapagos (GLPG) Belgium $1.878B 0.00
Ligand Pharmaceuticals (LGND) United States $1.852B 31.48
Certara (CERT) United States $1.826B 59.74
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.815B 0.00
NeoGenomics (NEO) United States $1.770B 0.00
Fortrea Holdings (FTRE) United States $1.760B 54.56
MannKind (MNKD) United States $1.721B 62.60
Arvinas (ARVN) United States $1.708B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.693B 0.00
NovoCure (NVCR) Jersey $1.611B 0.00
Disc Medicine (IRON) United States $1.567B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.561B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.558B 0.00
Viridian Therapeutics (VRDN) United States $1.508B 0.00
Dynavax Technologies (DVAX) United States $1.481B 102.73
Kura Oncology (KURA) United States $1.472B 0.00
Belite Bio (BLTE) United States $1.447B 0.00
Longboard Pharmaceuticals (LBPH) United States $1.443B 0.00
Nurix Therapeutics (NRIX) United States $1.423B 0.00
Arcus Biosciences (RCUS) United States $1.410B 0.00
Spyre Therapeutics (SYRE) United States $1.398B 0.00
Bicara Therapeutics (BCAX) $1.265B 0.00
ANI Pharmaceuticals (ANIP) United States $1.252B 16.99
Day One Biopharmaceuticals (DAWN) United States $1.229B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.228B 0.00
Tyra Biosciences (TYRA) United States $1.206B 0.00
Cogent Biosciences (COGT) United States $1.177B 0.00
Gyre Therapeutics (GYRE) United States $1.146B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.116B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.079B 0.00
Travere Therapeutics (TVTX) United States $1.070B 0.00
WAVE Life Sciences (WVE) Singapore $1.035B 0.00
Vir Biotechnology (VIR) United States $1.033B 0.00
Praxis Precision Medicines (PRAX) United States $1.020B 0.00
Phathom Pharmaceuticals (PHAT) United States $1.012B 0.00
Cullinan Therapeutics (CGEM) United States $0.972B 0.00
Applied Therapeutics (APLT) United States $0.964B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.958B 0.00
AnaptysBio (ANAB) United States $0.955B 0.00
Immatics (IMTX) Germany $0.949B 0.00
Mesoblast (MESO) Australia $0.944B 0.00
Sana Biotechnology (SANA) United States $0.943B 0.00
Prothena (PRTA) Ireland $0.895B 0.00
Zymeworks (ZYME) United States $0.877B 0.00
MiMedx (MDXG) United States $0.866B 24.58
IGM Biosciences (IGMS) United States $0.860B 0.00
CARGO Therapeutics (CRGX) United States $0.839B 0.00
Dianthus Therapeutics (DNTH) United States $0.818B 0.00
Replimune (REPL) United States $0.813B 0.00
Immunome (IMNM) United States $0.812B 0.00
ArriVent BioPharma (AVBP) United States $0.799B 0.00
Liquidia Technologies (LQDA) United States $0.785B 0.00
Tango Therapeutics (TNGX) United States $0.780B 0.00
Castle Biosciences (CSTL) United States $0.775B 0.00
MBX Biosciences (MBX) $0.766B 0.00
AbCellera Biologics (ABCL) Canada $0.757B 0.00
Rapport Therapeutics (RAPP) United States $0.743B 0.00
Adaptive Biotechnologies (ADPT) United States $0.740B 0.00
Erasca (ERAS) United States $0.732B 0.00
89BIO (ETNB) United States $0.724B 0.00
Arbutus Biopharma (ABUS) United States $0.723B 0.00
Cytek Biosciences (CTKB) United States $0.709B 0.00
Oric Pharmaceuticals (ORIC) United States $0.708B 0.00
Olema Pharmaceuticals (OLMA) United States $0.704B 0.00
Avid Bioservices (CDMO) United States $0.701B 0.00
Abivax SA (ABVX) France $0.694B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.680B 0.00
Zenas BioPharma (ZBIO) $0.678B 0.00
CureVac (CVAC) Germany $0.665B 0.00
Humacyte (HUMA) United States $0.656B 0.00
Stoke Therapeutics (STOK) United States $0.651B 0.00
Annexon (ANNX) United States $0.646B 0.00
Astria Therapeutics (ATXS) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Pliant Therapeutics (PLRX) United States $0.641B 0.00
LENZ Therapeutics (LENZ) United States $0.627B 0.00
Mineralys Therapeutics (MLYS) United States $0.611B 0.00
Scholar Rock Holding (SRRK) United States $0.596B 0.00
Entrada Therapeutics (TRDA) United States $0.595B 5.41
Y-mAbs Therapeutics (YMAB) United States $0.589B 0.00
Pharming Group (PHAR) Netherlands $0.583B 0.00
Nuvation Bio (NUVB) United States $0.573B 0.00
Terns Pharmaceuticals (TERN) United States $0.570B 0.00
Allogene Therapeutics (ALLO) United States $0.558B 0.00
Revance Therapeutics (RVNC) United States $0.545B 0.00
Celcuity (CELC) United States $0.540B 0.00
Third Harmonic Bio (THRD) United States $0.536B 0.00
Neurogene (NGNE) United States $0.519B 0.00
ACELYRIN, INC (SLRN) United States $0.508B 0.00
REGENXBIO (RGNX) United States $0.505B 0.00
Alumis (ALMS) United States $0.504B 0.00
Oculis Holding AG (OCS) Switzerland $0.490B 0.00
Q32 Bio (QTTB) United States $0.488B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.483B 0.00
Contineum Therapeutics (CTNM) United States $0.481B 0.00
Foghorn Therapeutics (FHTX) United States $0.480B 0.00
PureTech Health (PRTC) United States $0.467B 0.00
Anavex Life Sciences (AVXL) United States $0.461B 0.00
CorMedix Inc (CRMD) United States $0.452B 0.00
Emergent Biosolutions (EBS) United States $0.448B 0.00
Alector (ALEC) United States $0.443B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.428B 0.00
Aura Biosciences (AURA) United States $0.426B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.422B 0.00
Northwest Biotherapeutics (NWBO) United States $0.416B 0.00
Prime Medicine (PRME) United States $0.414B 0.00
Tectonic Therapeutic (TECX) United States $0.413B 0.00
GRAIL (GRAL) United States $0.411B 0.00
Absci (ABSI) United States $0.411B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.406B 0.00
Instil Bio (TIL) United States $0.398B 0.00
MaxCyte (MXCT) United States $0.389B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.389B 0.00
C4 Therapeutics (CCCC) United States $0.386B 0.00
Fate Therapeutics (FATE) United States $0.381B 0.00
Artiva Biotherapeutics (ARTV) United States $0.375B 0.00
AC Immune (ACIU) Switzerland $0.371B 0.00
Cartesian Therapeutics (RNAC) United States $0.366B 0.00
ITeos Therapeutics (ITOS) United States $0.365B 0.00
Anika Therapeutics (ANIK) United States $0.359B 173.36
Biomea Fusion (BMEA) United States $0.344B 0.00
Nautilus Biotechnology (NAUT) United States $0.339B 0.00
GH Research (GHRS) Ireland $0.334B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.325B 0.00
Voyager Therapeutics (VYGR) United States $0.319B 20.89
Corvus Pharmaceuticals (CRVS) United States $0.318B 0.00
XOMA Royalty (XOMA) United States $0.318B 0.00
Inozyme Pharma (INZY) United States $0.315B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.302B 0.00
Kamada (KMDA) Israel $0.301B 19.41
Alto Neuroscience (ANRO) United States $0.301B 0.00
Nkarta (NKTX) United States $0.297B 0.00
Urogen Pharma (URGN) United States $0.293B 0.00
Design Therapeutics (DSGN) United States $0.292B 0.00
PepGen (PEPG) United States $0.290B 0.00
EnGene Holdings (ENGN) Canada $0.288B 0.00
Sutro Biopharma (STRO) United States $0.287B 0.00
Atea Pharmaceuticals (AVIR) United States $0.281B 0.00
Abeona Therapeutics (ABEO) United States $0.280B 0.00
Ocugen (OCGN) United States $0.273B 0.00
ChromaDex (CDXC) United States $0.270B 0.00
Opthea (OPT) Australia $0.270B 0.00
Editas Medicine (EDIT) United States $0.270B 0.00
MeiraGTx Holdings (MGTX) United States $0.269B 0.00
Poseida Therapeutics (PSTX) United States $0.267B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.265B 0.00
TScan Therapeutics (TCRX) United States $0.264B 0.00
Solid Biosciences (SLDB) United States $0.262B 0.00
Compass Therapeutics (CMPX) United States $0.261B 0.00
Jasper Therapeutics (JSPR) United States $0.261B 0.00
Zura Bio (ZURA) United States $0.259B 0.00
Prima BioMed (IMMP) Australia $0.256B 0.00
Amarin (AMRN) Ireland $0.255B 0.00
Rezolute (RZLT) United States $0.254B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.254B 0.00
GENFIT S.A (GNFT) France $0.253B 0.00
Alpha Teknova (TKNO) United States $0.243B 0.00
Precigen (PGEN) United States $0.239B 0.00
Gossamer Bio (GOSS) United States $0.238B 0.00
2seventy Bio (TSVT) United States $0.237B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.236B 0.00
Black Diamond Therapeutics (BDTX) United States $0.236B 0.00
Cabaletta Bio (CABA) United States $0.227B 0.00
Trevi Therapeutics (TRVI) United States $0.226B 0.00
XBiotech (XBIT) United States $0.225B 0.00
UniQure (QURE) Netherlands $0.225B 0.00
Fulcrum Therapeutics (FULC) United States $0.225B 0.00
Mersana Therapeutics (MRSN) United States $0.224B 0.00
Candel Therapeutics (CADL) United States $0.224B 0.00
Inhibrx Biosciences (INBX) United States $0.224B 0.00
Codexis (CDXS) United States $0.216B 0.00
ScPharmaceuticals (SCPH) United States $0.211B 0.00
Kyverna Therapeutics (KYTX) United States $0.204B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.185B 0.00
Greenwich LifeSciences (GLSI) United States $0.182B 0.00
23andMe Holding (ME) United States $0.181B 0.00
DiaMedica Therapeutics (DMAC) United States $0.181B 0.00
Molecular Partners AG (MOLN) Switzerland $0.176B 0.00
Innate Pharma S.A (IPHA) France $0.174B 0.00
Sangamo Therapeutics (SGMO) United States $0.172B 0.00
Scilex Holding (SCLX) United States $0.171B 0.00
Caribou Biosciences (CRBU) United States $0.165B 0.00
Compugen (CGEN) Israel $0.165B 0.00
BioStem Technologies (BSEM) $0.164B 25.72
Generation Bio (GBIO) United States $0.158B 0.00
Eton Pharmaceuticals (ETON) United States $0.153B 0.00
Lifecore Biomedical (LFCR) United States $0.150B 0.00
Tenaya Therapeutics (TNYA) United States $0.148B 0.00
Repare Therapeutics (RPTX) Canada $0.147B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.147B 0.00
Ventyx Biosciences (VTYX) United States $0.147B 0.00
Seres Therapeutics (MCRB) United States $0.146B 0.00
Inovio Pharmaceuticals (INO) United States $0.146B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.144B 0.00
Immunic (IMUX) United States $0.143B 0.00
Akoya Biosciences (AKYA) United States $0.140B 0.00
Adverum Biotechnologies (ADVM) United States $0.137B 0.00
Kodiak Sciences (KOD) United States $0.137B 0.00
Actuate Therapeutics (ACTU) United States $0.135B 0.00
PDS Biotechnology (PDSB) United States $0.134B 0.00
Vigil Neuroscience (VIGL) United States $0.133B 0.00
Adherex Technologies (FENC) United States $0.132B 120.50
Elutia (ELUT) United States $0.130B 0.00
ATyr Pharma (ATYR) United States $0.130B 0.00
Puma Biotechnology (PBYI) United States $0.128B 13.68
Oncobiologics (OTLK) United States $0.123B 0.00
Rani Therapeutics Holdings (RANI) United States $0.123B 0.00
Seer (SEER) United States $0.119B 0.00
Nuvectis Pharma (NVCT) United States $0.119B 0.00
Coherus BioSciences (CHRS) United States $0.118B 0.00
Adicet Bio (ACET) United States $0.117B 0.00
Benitec Biopharma (BNTC) United States $0.116B 0.00
Cardiff Oncology (CRDF) United States $0.115B 0.00
Verastem (VSTM) United States $0.113B 0.00
Cellectis S.A (CLLS) France $0.112B 0.00
Skye Bioscience (SKYE) United States $0.112B 0.00
Agenus (AGEN) United States $0.110B 0.00
INmune Bio (INMB) United States $0.109B 0.00
Invivyd (IVVD) United States $0.108B 0.00
X4 Pharmaceuticals (XFOR) United States $0.107B 0.00
Annovis Bio (ANVS) United States $0.104B 0.00
FibroBiologics (FBLG) United States $0.102B 0.00
Coya Therapeutics (COYA) United States $0.102B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.101B 0.00
Clearside Biomedical (CLSD) United States $0.100B 0.00
MediciNova (MNOV) United States $0.100B 0.00
I-Mab (IMAB) China $0.099B 0.00
Checkpoint Therapeutics (CKPT) United States $0.099B 0.00
ALX Oncology Holdings (ALXO) United States $0.098B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.097B 0.00
Adagene (ADAG) China $0.097B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.096B 0.00
Sagimet Biosciences (SGMT) United States $0.096B 0.00
BeyondSpring (BYSI) United States $0.094B 0.00
Inventiva S.A (IVA) France $0.093B 0.00
BioHarvest Sciences (CNVCF) Canada $0.093B 0.00
Shattuck Labs (STTK) United States $0.092B 0.00
Bluebird Bio (BLUE) United States $0.091B 0.00
CytomX Therapeutics (CTMX) United States $0.090B 8.21
InflaRx (IFRX) Germany $0.089B 0.00
CervoMed (CRVO) United States $0.089B 0.00
HilleVax (HLVX) United States $0.089B 0.00
Werewolf Therapeutics (HOWL) United States $0.087B 0.00
BioAtla (BCAB) United States $0.084B 0.00
VistaGen Therapeutics (VTGN) United States $0.083B 0.00
Ikena Oncology (IKNA) United States $0.082B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.080B 0.00
Chimerix (CMRX) United States $0.080B 0.00
Ovid Therapeutics (OVID) United States $0.079B 0.00
Aileron Therapeutics (ALRN) United States $0.078B 0.00
Genelux (GNLX) United States $0.078B 0.00
Connect Biopharma Holdings (CNTB) United States $0.078B 0.00
Galena Biopharma (SLS) United States $0.078B 0.00
Cidara Therapeutics (CDTX) United States $0.075B 0.00
Genenta Science S.p.A (GNTA) Italy $0.074B 0.00
Adlai Nortye (ANL) Cayman Islands $0.074B 0.00
Boundless Bio (BOLD) United States $0.073B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.072B 0.00
Spero Therapeutics (SPRO) United States $0.071B 3.20
DBV Technologies S.A (DBVT) France $0.070B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.070B 0.00
IO Biotech (IOBT) Denmark $0.069B 0.00
Immuneering (IMRX) United States $0.069B 0.00
Renovaro (RENB) United States $0.068B 0.00
Oncolytics Biotech (ONCY) Canada $0.066B 0.00
Omega Therapeutics (OMGA) United States $0.066B 0.00
Precision BioSciences (DTIL) United States $0.066B 0.00
Entera Bio (ENTX) Israel $0.065B 0.00
Celularity (CELU) United States $0.065B 0.00
Rapt Therapeutics (RAPT) United States $0.065B 0.00
Imunon (IMNN) United States $0.064B 0.00
LakeShore Biopharma (LSB) China $0.063B 0.00
TELA Bio (TELA) United States $0.062B 0.00
Leap Therapeutics (LPTX) United States $0.062B 0.00
Aerovate Therapeutics (AVTE) United States $0.060B 0.00
Kronos Bio (KRON) United States $0.059B 0.00
Kezar Life Sciences (KZR) United States $0.058B 0.00
ZIVO Bioscience (ZIVO) United States $0.057B 0.00
Enzo Biochem (ENZ) United States $0.057B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.056B 0.00
Theratechnologies (THTX) Canada $0.056B 0.00
Allakos (ALLK) United States $0.055B 0.00
Elicio Therapeutics (ELTX) United States $0.054B 0.00
Intensity Therapeutics (INTS) United States $0.053B 0.00
Semper Paratus Acquisition (TVGN) United States $0.052B 0.00
Earth Science Tech (ETST) United States $0.052B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.051B 0.00
Syros Pharmaceuticals (SYRS) United States $0.051B 0.00
Affimed (AFMD) Germany $0.050B 0.00
Lexaria Bioscience (LEXX) Canada $0.050B 0.00
HOOKIPA Pharma (HOOK) United States $0.049B 0.00
Aadi Bioscience (AADI) United States $0.048B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.047B 0.00
Rallybio (RLYB) United States $0.046B 0.00
Estrella Immunopharma (ESLA) United States $0.046B 0.00
CalciMedica (CALC) United States $0.045B 0.00
Vor Biopharma (VOR) $0.044B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.041B 0.00
VTv Therapeutics (VTVT) United States $0.041B 0.00
Immix Biopharma (IMMX) United States $0.041B 0.00
Lantern Pharma (LTRN) United States $0.040B 0.00
Passage Bio (PASG) United States $0.040B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.039B 0.00
Atara Biotherapeutics (ATRA) United States $0.038B 0.00
Promis Neurosciences (PMN) Canada $0.037B 0.00
NextCure (NXTC) United States $0.037B 0.00
Bionano Genomics (BNGO) United States $0.037B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.036B 0.00
OKYO Pharma (OKYO) $0.035B 0.00
Cue Biopharma (CUE) United States $0.035B 0.00
Quince Therapeutics (QNCX) United States $0.034B 0.00
Elevation Oncology (ELEV) United States $0.033B 0.00
Ocuphire Pharma (OCUP) United States $0.033B 0.00
Xilio Therapeutics (XLO) United States $0.033B 0.00
Fortress Biotech (FBIO) United States $0.033B 0.00
Eyenovia (EYEN) United States $0.032B 0.00
Ocean Biomedical (OCEA) United States $0.032B 0.00
Clene (CLNN) United States $0.032B 0.00
Curis (CRIS) United States $0.031B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.031B 0.00
Dyadic (DYAI) United States $0.030B 0.00
Equillium (EQ) United States $0.030B 0.00
Pluri (PLUR) Israel $0.029B 0.00
Lumos Pharma (LUMO) United States $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
BioAffinity Technologies (BIAF) United States $0.028B 0.00
Aligos Therapeutics (ALGS) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.027B 0.00
Longeveron (LGVN) United States $0.027B 0.00
Gritstone Bio (GRTS) United States $0.026B 0.00
KALA BIO (KALA) United States $0.025B 0.00
Femasys (FEMY) United States $0.025B 0.00
BRIACELL THERAP (BCTX) Canada $0.025B 0.00
Bolt Biotherapeutics (BOLT) United States $0.025B 0.00
RenovoRx (RNXT) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
UNITY Biotechnology (UBX) United States $0.024B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.024B 0.00
SAB Biotherapeutics (SABS) United States $0.024B 0.00
BioXcel Therapeutics (BTAI) United States $0.023B 0.00
Cyclo Therapeutics (CYTH) United States $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
Orgenesis (ORGS) United States $0.021B 0.00
Vincerx Pharma (VINC) United States $0.020B 0.00
Spruce Biosciences (SPRB) United States $0.019B 0.00
HCW Biologics (HCWB) United States $0.019B 0.00
GeoVax Labs (GOVX) United States $0.018B 0.00
Biora Therapeutics (BIOR) United States $0.018B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.018B 0.00
Monopar Therapeutics (MNPR) United States $0.018B 0.00
Cognition Therapeutics (CGTX) United States $0.018B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.018B 0.00
Cocrystal Pharma (COCP) United States $0.017B 0.00
Athira Pharma (ATHA) United States $0.017B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
Evaxion Biotech (EVAX) Denmark $0.016B 0.00
IMMURON (IMRN) Australia $0.016B 0.00
Cara Therapeutics (CARA) United States $0.016B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
Aytu BioPharma (AYTU) United States $0.014B 0.00
Aprea Therapeutics (APRE) United States $0.014B 0.00
Beyond Air (XAIR) United States $0.014B 0.00
Cadrenal Therapeutics (CVKD) United States $0.014B 0.00
NKGen Biotech (NKGN) United States $0.014B 0.00
Apollomics (APLM) United States $0.013B 0.00
Galecto (GLTO) Denmark $0.013B 0.00
Sensei Biotherapeutics (SNSE) United States $0.012B 0.00
Turnstone Biologics (TSBX) United States $0.012B 0.00
IN8bio (INAB) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.012B 0.00
Tenax Therapeutics (TENX) United States $0.012B 0.00
Novogen (KZIA) Australia $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Kintara Therapeutics (KTRA) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Carmell (CTCX) United States $0.009B 0.00
Soligenix (SNGX) United States $0.009B 0.00
Mustang Bio (MBIO) United States $0.008B 0.00
Aptose Biosciences (APTO) Canada $0.008B 0.00
ABVC BioPharma (ABVC) United States $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Forte Biosciences (FBRX) United States $0.008B 0.00
Purple Biotech (PPBT) Israel $0.007B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
Organovo Holdings (ONVO) United States $0.007B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Biofrontera (BFRI) United States $0.007B 0.00
Portage Biotech (PRTG) $0.006B 0.00
BioCardia (BCDA) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Vaccinex (VCNX) United States $0.006B 0.00
NuCana (NCNA) United Kingdom $0.005B 0.00
Silexion Therapeutics Corp (SLXN) United States $0.005B 0.00
Exicure (XCUR) United States $0.005B 0.00
Eterna Therapeutics (ERNA) United States $0.005B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.005B 0.00
Quantum Biopharma (QNTM) Canada $0.005B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
AquaBounty Technologies (AQB) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Cingulate (CING) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Virios Therapeutics (VIRI) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Notable Labs (NTBL) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Bone Biologics (BBLG) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Trevena (TRVN) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Bionomics (BNOX) Australia $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Allarity Therapeutics (ALLR) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Ensysce Biosciences (ENSC) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Elevai Labs (ELAB) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Windtree Therapeutics (WINT) United States $0.001B 0.00
Seelos Therapeutics (SEEL) United States $0.001B 0.00
Psyence Biomedical (PBM) Canada $0.001B 0.00
Entero Therapeutics (ENTO) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
GENPREX (GNPX) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00